Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
$331M |
| 2 |
Chevron
CVX
|
$266M |
| 3 |
Chipotle Mexican Grill
CMG
|
$259M |
| 4 |
JPMorgan Chase
JPM
|
$232M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
$223M |
Top Sells
| 1 |
Apple
AAPL
|
$707M |
| 2 |
Johnson & Johnson
JNJ
|
$411M |
| 3 |
Amazon
AMZN
|
$312M |
| 4 |
Walmart
WMT
|
$285M |
| 5 |
Intuitive Surgical
ISRG
|
$282M |
Sector Composition
| 1 | Healthcare | 17.74% |
| 2 | Technology | 14.99% |
| 3 | Financials | 10.9% |
| 4 | Consumer Discretionary | 8.96% |
| 5 | Real Estate | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
VeriSign
VRSN
$25.5B
| $1.13B | 1.16% | 7,037,800 +122,700 | +2% | +$19.6M |
|
2
Align Technology
ALGN
$10.3B
| $1.09B | 1.12% | 2,778,381 -116,419 | -4% | -$45.5M |
|
3
Humana
HUM
$36.5B
| $1.07B | 1.1% | 3,174,800 +391,300 | +14% | +$132M |
|
4
Palo Alto Networks
PANW
$127B
| $1.05B | 1.08% | 4,651,200 +925,500 | +25% | +$208M |
|
5
Domino's
DPZ
$15.6B
| $939M | 0.96% | 3,183,800 -267,700 | -8% | -$78.9M |
|
6
Novo Nordisk
NVO
$251B
| $927M | 0.95% | 19,666,671 +524,371 | +3% | +$24.7M |
|
7
Amgen
AMGN
$155B
| $853M | 0.88% | 4,115,145 +311,545 | +8% | +$64.6M |
|
|
VMW
8
DELISTED
VMware, Inc
VMW
| $802M | 0.82% | 5,136,168 -153,632 | -3% | -$24M |
|
9
Vertex Pharmaceuticals
VRTX
$100B
| $788M | 0.81% | 4,089,117 +38,500 | +1% | +$7.42M |
|
|
ABMD
10
DELISTED
Abiomed Inc
ABMD
| $773M | 0.79% | 1,719,023 +167,600 | +11% | +$75.4M |
|
11
PepsiCo
PEP
$204B
| $740M | 0.76% | 6,620,250 -342,600 | -5% | -$38.3M |
|
12
Progressive
PGR
$145B
| $605M | 0.62% | 8,511,700 +1,416,800 | +20% | +$101M |
|
13
Crown Castle
CCI
$43.2B
| $602M | 0.62% | 5,405,300 +115,597 | +2% | +$12.9M |
|
14
NVIDIA
NVDA
$4.24T
| $588M | 0.6% | 2,091,465 +601,672 | +40% | +$169M |
|
15
Bristol-Myers Squibb
BMY
$96B
| $580M | 0.6% | 9,344,000 -1,203,200 | -11% | -$74.7M |
|
16
Molina Healthcare
MOH
$9.8B
| $556M | 0.57% | 3,738,755 +932,905 | +33% | +$139M |
|
17
BP
BP
$90.8B
| $550M | 0.57% | 11,921,446 +2,863,902 | +32% | +$132M |
|
18
Meta Platforms (Facebook)
META
$1.86T
| $548M | 0.56% | 3,332,556 +865,068 | +35% | +$142M |
|
19
Duke Energy
DUK
$95.3B
| $484M | 0.5% | 6,051,129 +1,980,562 | +49% | +$158M |
|
20
Dell
DELL
$82.6B
| $483M | 0.5% | 4,974,600 -575,100 | -10% | -$55.9M |
|
21
FirstEnergy
FE
$25.2B
| $458M | 0.47% | 12,312,308 +304,900 | +3% | +$11.3M |
|
|
AZPN
22
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $456M | 0.47% | 4,002,003 +139,203 | +4% | +$15.9M |
|
23
Idexx Laboratories
IDXX
$51.8B
| $444M | 0.46% | 1,778,004 -391,925 | -18% | -$97.8M |
|
24
Colgate-Palmolive
CL
$67.9B
| $444M | 0.46% | 6,627,800 -573,100 | -8% | -$38.4M |
|
25
Cboe Global Markets
CBOE
$24.7B
| $439M | 0.45% | 4,570,700 -619,500 | -12% | -$59.4M |
|